Royalty Pharma RPRX
NASDAQ RPRX
$57.63 -0.73 (-1.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Royalty Pharma's Liabilities and Shareholders Equity was $19.82 billion in Q2 2026, up 8.2% from $18.32 billion a year earlier and unchanged from the prior quarter.

Analysis

Royalty Pharma (RPRX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Royalty Pharma came in at $19.62 billion, up 7.7% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $18.22 billion in FY2024 (+11.2%), $16.38 billion in FY2023 (-2.6%), $16.81 billion in FY2022 (-4.0%) and $17.52 billion in FY2021 (+9.3%).
  • The Q2 2026 figure marks the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2019.
  • Compared with a year earlier, Liabilities and Shareholders Equity has increased for nine straight quarters, with growth averaging 9.2% over the last eight quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2024 (growth of 13.8%); the worst was Q3 2023 (a decline of 10.3%).
  • Per Business Quant data, RPRX's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $19.82 billion (Q1 2026), $19.62 billion (Q4 2025) and $19.35 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Rocket Companies 43.26 Bn 28.94 Bn - 60.98 Bn
2 Orix 42.40 Bn 42.90 Bn - 114.54 Bn
3 Royalty Pharma 33.56 Bn 33.47 Bn - 19.82 Bn
4 Federal National Mortgage Association Fannie Mae 24.47 Bn 24.47 Bn - 4,332.34 Bn
5 Affirm Holdings 23.34 Bn 17.03 Bn - 15.79 Bn
6 Synchrony Financial 23.06 Bn -44.91 Bn - 121.93 Bn
7 Royal Gold 19.98 Bn 19.21 Bn 390.45 Mn 9.45 Bn
8 Annaly Capital Management 14.18 Bn 5.27 Bn - 143.74 Bn
9 Ares Capital 13.71 Bn 11.15 Bn - 30.50 Bn
10 Federal Home Loan Mortgage 12.39 Bn -6.35 Bn - 3,518.32 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.82 Bn
Mar 31, 2026 19.82 Bn
Dec 31, 2025 19.62 Bn
Sep 30, 2025 19.35 Bn
Jun 30, 2025 18.32 Bn
Mar 31, 2025 17.61 Bn
Dec 31, 2024 18.22 Bn
Sep 30, 2024 18.04 Bn
Jun 30, 2024 17.66 Bn
Mar 31, 2024 16.13 Bn
Dec 31, 2023 16.38 Bn
Sep 30, 2023 15.86 Bn
Jun 30, 2023 17.12 Bn
Mar 31, 2023 17.07 Bn
Dec 31, 2022 16.81 Bn
Sep 30, 2022 17.67 Bn
Jun 30, 2022 17.74 Bn
Mar 31, 2022 17.38 Bn
Dec 31, 2021 17.52 Bn
Sep 30, 2021 17.73 Bn
API Access

Royalty Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RPRX&period=max&api_key=YOUR_API_KEY